343 related articles for article (PubMed ID: 17200176)
1. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism.
Xu N; Qin Y; Reindollar RH; Tho SP; McDonough PG; Layman LC
J Clin Endocrinol Metab; 2007 Mar; 92(3):1155-8. PubMed ID: 17200176
[TBL] [Abstract][Full Text] [Related]
2. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
[TBL] [Abstract][Full Text] [Related]
3. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
[TBL] [Abstract][Full Text] [Related]
4. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
[TBL] [Abstract][Full Text] [Related]
5. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
[TBL] [Abstract][Full Text] [Related]
6. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
[TBL] [Abstract][Full Text] [Related]
7. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
Pitteloud N; Quinton R; Pearce S; Raivio T; Acierno J; Dwyer A; Plummer L; Hughes V; Seminara S; Cheng YZ; Li WP; Maccoll G; Eliseenkova AV; Olsen SK; Ibrahimi OA; Hayes FJ; Boepple P; Hall JE; Bouloux P; Mohammadi M; Crowley W
J Clin Invest; 2007 Feb; 117(2):457-63. PubMed ID: 17235395
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations.
Akkuş G; Kotan LD; Durmaz E; Mengen E; Turan İ; Ulubay A; Gürbüz F; Yüksel B; Tetiker T; Topaloğlu AK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):95-100. PubMed ID: 28008864
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.
Quinton R; Duke VM; Robertson A; Kirk JM; Matfin G; de Zoysa PA; Azcona C; MacColl GS; Jacobs HS; Conway GS; Besser M; Stanhope RG; Bouloux PM
Clin Endocrinol (Oxf); 2001 Aug; 55(2):163-74. PubMed ID: 11531922
[TBL] [Abstract][Full Text] [Related]
10. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics.
Oliveira LM; Seminara SB; Beranova M; Hayes FJ; Valkenburgh SB; Schipani E; Costa EM; Latronico AC; Crowley WF; Vallejo M
J Clin Endocrinol Metab; 2001 Apr; 86(4):1532-8. PubMed ID: 11297579
[TBL] [Abstract][Full Text] [Related]
11. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
[TBL] [Abstract][Full Text] [Related]
12. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
[TBL] [Abstract][Full Text] [Related]
13. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
[TBL] [Abstract][Full Text] [Related]
14. Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH).
Koika V; Varnavas P; Valavani H; Sidis Y; Plummer L; Dwyer A; Quinton R; Kanaka-Gantenbein C; Pitteloud N; Sertedaki A; Dacou-Voutetakis C; Georgopoulos NA
Gene; 2013 Mar; 516(1):146-51. PubMed ID: 23276709
[TBL] [Abstract][Full Text] [Related]
15. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).
Zenaty D; Bretones P; Lambe C; Guemas I; David M; Léger J; de Roux N
Mol Cell Endocrinol; 2006 Jul; 254-255():78-83. PubMed ID: 16757108
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism.
Bhagavath B; Podolsky RH; Ozata M; Bolu E; Bick DP; Kulharya A; Sherins RJ; Layman LC
Fertil Steril; 2006 Mar; 85(3):706-13. PubMed ID: 16500342
[TBL] [Abstract][Full Text] [Related]
17. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1.
Trarbach EB; Teles MG; Costa EM; Abreu AP; Garmes HM; Guerra G; Baptista MT; de Castro M; Mendonca BB; Latronico AC
Clin Endocrinol (Oxf); 2010 Mar; 72(3):371-6. PubMed ID: 19489874
[TBL] [Abstract][Full Text] [Related]
18. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.
Raivio T; Sidis Y; Plummer L; Chen H; Ma J; Mukherjee A; Jacobson-Dickman E; Quinton R; Van Vliet G; Lavoie H; Hughes VA; Dwyer A; Hayes FJ; Xu S; Sparks S; Kaiser UB; Mohammadi M; Pitteloud N
J Clin Endocrinol Metab; 2009 Nov; 94(11):4380-90. PubMed ID: 19820032
[TBL] [Abstract][Full Text] [Related]
19. Novel FGFR1 and KISS1R Mutations in Chinese Kallmann Syndrome Males with Cleft Lip/Palate.
Xu H; Niu Y; Wang T; Liu S; Xu H; Wang S; Liu J; Ye Z
Biomed Res Int; 2015; 2015():649698. PubMed ID: 26199944
[TBL] [Abstract][Full Text] [Related]
20. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.
Pitteloud N; Acierno JS; Meysing AU; Dwyer AA; Hayes FJ; Crowley WF
J Clin Endocrinol Metab; 2005 Mar; 90(3):1317-22. PubMed ID: 15613419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
